Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Drew Armstrong
Stay informed with Drew Armstrong’s coverage and analysis for Fortune.
Health
Pfizer says it will slash drug prices for the poorest nations. But the devil is in the details
By
Drew Armstrong
and
Bloomberg
From Brussels to Sydney, cities around the world are lifting COVID-19 travel restrictions
By
Drew Armstrong
,
Demetrios Pogkas
, and others
Health
Biden plans to donate an additional 500 million Pfizer shots abroad
By
Josh Wingrove
,
Drew Armstrong
, and others
Health
CDC recruits outsiders to lead a new center on disease forecasting
By
Drew Armstrong
,
Fiona Rutherford
, and others
International
Germany funded the development of Pfizer’s COVID vaccine—not U.S.’s Operation Warp Speed
By
Riley Griffin
,
Drew Armstrong
, and others
Health
Trump names 2 new heads of ‘Operation Warp Speed,’ the effort to develop coronavirus vaccine
By
Jennifer Jacobs
,
Drew Armstrong
, and others
Politics
The U.S. has a new plan to fast-track a COVID-19 vaccine: ‘Operation Warp Speed’
By
Jennifer Jacobs
,
Drew Armstrong
, and others
Finance
Gilead shares tumble on reports that the Chinese trial of its coronavirus drug was not successful
By
Drew Armstrong
,
Robert Langreth
, and others
Health
Gilead stock surges on report of coronavirus drug patients ‘seeing rapid recoveries’
By
Drew Armstrong
and
Bloomberg
Health
The U.S. can’t contain coronavirus, it just hopes to mitigate its impact
By
Daniel Flatley
,
Drew Armstrong
, and others
Health
Coronavirus: Fewer than 6,000 samples have been tested in the U.S.
By
Jennifer Jacobs
,
Drew Armstrong
, and others
Politics
Slashing Cigarette Nicotine Levels No Longer on FDA’s Agenda
By
Drew Armstrong
and
Bloomberg
MPW
Rite Aid Names New CEO, Brings Number of Women CEOs on Fortune 500 to Record High
By
Drew Armstrong
and
Bloomberg